Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia

C. Qiu, T. T. T. Phung, S. Vadachkoria, M. Muy-Rivera, S. E. Sanchez, M. A. Williams

. 2006 ; 55 (5) : 491-500.

Jazyk angličtina Země Česko

Typ dokumentu srovnávací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc07500523

Oxidative stress plays an important role in the pathophysiology of preeclampsia. In a case-control study of 99 women with preeclampsia and 99 controls, we assessed maternal plasma oxidized low-density lipoprotein (oxidized LDL) in relation to preeclampsia risk. Logistic regression procedures were used to derive odds ratios (OR) and 95 % confidence intervals (CI). Plasma oxidized LDL was determined using enzyme immunoassay. Maternal plasma oxidized LDL was significantly positively correlated with lipids in both cases and controls. After adjusting for nulliparity, pre-pregnancy body mass index, physical inactivity, family history of chronic hypertension and plasma vitamin C concentrations, women who had elevated oxidized LDL concentrations (?50 U/l) experienced a 2.9-fold increased risk of preeclampsia when compared with women having lower oxidized LDL concentrations (95 % CI 1.4-5.9). The risk of preeclampsia was markedly increased in women who had both elevated oxidized LDL and elevated triglyceride concentrations (OR=8.9, 95 % CI 3.1-26.2). Women with both elevated oxidized LDL and low vitamin C concentrations experienced a 9.8-fold increased risk of preeclampsia (95 % CI 3.0-32.2). Our results confirm the role of oxidative stress in the pathogenesis of preeclampsia. Prospective studies are needed to determine if elevated oxidized LDL concentrations can predict the occurrence of preeclampsia.

Grant č. R01-32562 HD

Bibliografie atd.

Lit.: 37

000      
03355naa 2200481 a 4500
001      
bmc07500523
003      
CZ-PrNML
005      
20111210120856.0
008      
070724s2006 xr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Qiu, C.
245    10
$a Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia / $c C. Qiu, T. T. T. Phung, S. Vadachkoria, M. Muy-Rivera, S. E. Sanchez, M. A. Williams
314    __
$a Center for Perinatal Studies, Swedish Medical Center, Seattle
500    __
$a Grant č. R01-32562 HD
504    __
$a Lit.: 37
520    9_
$a Oxidative stress plays an important role in the pathophysiology of preeclampsia. In a case-control study of 99 women with preeclampsia and 99 controls, we assessed maternal plasma oxidized low-density lipoprotein (oxidized LDL) in relation to preeclampsia risk. Logistic regression procedures were used to derive odds ratios (OR) and 95 % confidence intervals (CI). Plasma oxidized LDL was determined using enzyme immunoassay. Maternal plasma oxidized LDL was significantly positively correlated with lipids in both cases and controls. After adjusting for nulliparity, pre-pregnancy body mass index, physical inactivity, family history of chronic hypertension and plasma vitamin C concentrations, women who had elevated oxidized LDL concentrations (?50 U/l) experienced a 2.9-fold increased risk of preeclampsia when compared with women having lower oxidized LDL concentrations (95 % CI 1.4-5.9). The risk of preeclampsia was markedly increased in women who had both elevated oxidized LDL and elevated triglyceride concentrations (OR=8.9, 95 % CI 3.1-26.2). Women with both elevated oxidized LDL and low vitamin C concentrations experienced a 9.8-fold increased risk of preeclampsia (95 % CI 3.0-32.2). Our results confirm the role of oxidative stress in the pathogenesis of preeclampsia. Prospective studies are needed to determine if elevated oxidized LDL concentrations can predict the occurrence of preeclampsia.
650    _2
$a preeklampsie $x etiologie $x metabolismus $7 D011225
650    _2
$a lipoproteiny LDL $x krev $x metabolismus $7 D008077
650    _2
$a oxidační stres $x genetika $7 D018384
650    _2
$a peroxidace lipidů $x genetika $x účinky léků $7 D015227
650    _2
$a rizikové faktory $7 D012307
650    _2
$a hypertenze $x etiologie $x komplikace $x metabolismus $7 D006973
650    _2
$a kyselina askorbová $x krev $x metabolismus $7 D001205
650    _2
$a interpretace statistických dat $7 D003627
650    _2
$a lidé $7 D006801
650    _2
$a financování vládou $7 D005380
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Phung, T. T. T.
700    1_
$a Vadachkoria, S.
700    1_
$a Muy-Rivera, M.
700    1_
$a Sanchez, S. E.
700    1_
$a Williams, M. A.
773    0_
$w MED00003824 $t Physiological research $g Roč. 55, č. 5 (2006), s. 491-500 $x 0862-8408
856    41
$u https://www.biomed.cas.cz/physiolres/pdf/55/55_491.pdf $y plný text volně přístupný
910    __
$y 1 $a ABA008 $b A 4120 $c 266
990    __
$a 20070723155916 $b ABA008
991    __
$a 20070727102207 $b ABA008
999    __
$a ok $b bmc $g 616137 $s 468569
BAS    __
$a 3
BMC    __
$a 2006 $b 55 $c 5 $d 491-500 $i 0862-8408 $m Physiological research $x MED00003824
LZP    __
$a 2007-5/mkal

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...